Lactulose enemas in the treatment of hepatic encephalopathy: do we help or harm?

Lactulose enemas in the treatment of hepatic encephalopathy: do we help or harm?

Bibliographic Details
Main Authors:	Ana de Lorenzo-Pinto, Raquel García-Sánchez, Almudena Lorenzo-Salinas
Format:	Article
Language:	English
Published:	Aran Ediciones
Series:	Revista Espanola de Enfermedades Digestivas
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017001000015&lng=en&tlng=en

Similar Items

Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy
by: Ahmad Shavakhi, et al.
Published: (2014-01-01)

Comparing efficacy of Rifaximin plus Lactulose vs. Lactulose alone in treating Hepatic Encephalopathy
by: Tanveer Hussain, et al.
Published: (2020-12-01)

Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose
by: Praveen Sharma, et al.
Published: (2011-01-01)

Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial
by: Mohammadreza Naderian, et al.
Published: (2017-01-01)

Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy
by: Nan Yang, et al.
Published: (2015-01-01)

Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction
by: Praveen Sharma, et al.
Published: (2012-01-01)

Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis
by: Mohamad Fekredeen Ayas, et al.
Published: (2021-09-01)

Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
by: Wang Z, et al.
Published: (2018-12-01)

Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding
by: Felipe Toyama Aires, et al.
Published: (2016-06-01)

Effect of adjuvant lactulose enema therapy on outcome and intestinal mucosal barrier function in patients with acute pancreatitis
by: Ling Gao, et al.
Published: (2016-10-01)

Factors associated with non-response to lactulose therapy in cirrhotic patients with minimal hepatic encephalopathy
by: Shireen Ahmed, et al.
Published: (2018-01-01)

The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
by: Koichi Narita, et al.
Published: (2020-01-01)

Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan
by: Ching Chang, et al.
Published: (2021-05-01)

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study
by: Jorge Luis Poo, et al.
Published: (2006-10-01)

Rifaximin as treatment for hepatic encephalopathy: Some considerations
by: Lorenzo Ridola, et al.
Published: (2013-01-01)

A comparative study to determine the short-term mortality and clinical improvement in hepatic encephalopathy using either rifaximin and or lactulose
by: Uttam Biswas, et al.
Published: (2021-03-01)

Minimal hepatic encephalopathy. Should we treat it?
by: Liz Toapanta-Yanchapaxi, et al.
Published: (2013-05-01)

Lactulose to the Rescue: A Case of Toxic Hepatic Encephalopathy Caused by Portosystemic Shunting and Epistaxis in a Patient with Hereditary Hemorrhagic Telangiectasia
by: Ruchit N. Shah, et al.
Published: (2019-01-01)

Liquid Diagnosis of Hepatic Encephalopathy: Are We There Already?
by: Mariana Verdelho Machado
Published: (2020-09-01)

Lactulose Improves Neurological Outcomes by Repressing Harmful Bacteria and Regulating Inflammatory Reactions in Mice After Stroke
by: Quan Yuan, et al.
Published: (2021-07-01)

Diagnosis and treatment of hepatic encephalopathy
by: Ilona Savlan, et al.
Published: (2013-05-01)

Treatment of minimal hepatic encephalopathy
by: ZHAO Kai
Published: (2014-10-01)

Rifaximin in the treatment of hepatic encephalopathy
by: Iadevaia MD, et al.
Published: (2011-12-01)

Hepatic Encephalopathy in the 21st Century: Still an Emerging Topic
by: Lorenzo Ridola, et al.
Published: (2021-01-01)

Nutritional support in the treatment of chronic hepatic encephalopathy
by: María del Pilar Milke García
Published: (2011-01-01)

Herbal enema: At the cost of colon
by: Parmanand Prasad, et al.
Published: (2012-01-01)

Pattern of methane levels with lactulose breath testing; can we shorten the test duration?
by: Anisa Shaker, et al.
Published: (2021-07-01)

Current trends in the treatment of hepatic encephalopathy
by: Mohamad Rasm Al Sibae, et al.
Published: (2009-07-01)

Is flumazenil an alternative for the treatment of hepatic encephalopathy?
by: Diego Reyes, et al.
Published: (2017-12-01)

REGULARITIES OF THE DRYING OF LACTULOSE SOLUTIONS
by: Kozlova O.V., et al.
Published: (2013-12-01)

The metabolism of lactulose by intestinal bacteria
by: Sahota, Surinder Singh
Published: (1987)

Dishonest helping and harming after (un)fair treatment
by: Margarita Leib, et al.
Published: (2019-07-01)

Hepatic encephalopathy
by: Wissam Bleibel, et al.
Published: (2012-01-01)

HEPATIC ENCEPHALOPATHY
by: Aleksandar Nagorni, et al.
Published: (2005-01-01)

Dual-use: Helpful or harmful?
by: Anusha Divvi, et al.
Published: (2019-12-01)

Research progress in the treatment of diabetic kidney disease with Chinese medicine enema
by: Rui Wu, et al.
Published: (2021-07-01)

A new enema for treatment of intussusception with hydrostatic reduction: Olive oil
by: Burhan Beger, et al.
Published: (2019-01-01)

Efficacy of 5-Aminosalicylic Acid Enemas in the Treatment of Distal Ulcerative Colitis
by: MG Robinson, et al.
Published: (1990-01-01)

Hepatic encephalopathy in clinical practice: diagnosis and treatment
by: T. N. Lopatkina, et al.
Published: (2013-12-01)

Pathophysiology of hepatic encephalopathy and future treatment options
by: J.A. González-Regueiro, et al.
Published: (2019-04-01)